Professor Erika Lietzan has launched a new blog, Objective Intent. In this blog, she and a co-author, Professor Patricia Zettler of Georgia State University, explore legal and policy issues associated with the U.S. Food and Drug Administration (FDA).
Before joining the faculty of the University of Missouri, Professor Lietzan practiced FDA law for 18 years with one of the country’s premier food and drug law practices. Before joining Georgia State, Professor Zettler was an associate chief counsel in FDA’s Office of the Chief Counsel. The two are uniquely positioned to provide timely, thoughtful and informed commentary on FDA law and policy.
The title of the blog, “Objective Intent,” comes from FDA regulations that define “intended use.” This title both pays homage to the critical role that a product’s intended use plays in many FDA controversies and reflects their hope that the blog will serve as a space for objective reflection on FDA issues by legal academics.